Oncology Institute Inc (TOI)

Currency in USD
3.430
+0.050(+1.48%)
Closed·
3.480+0.050(+1.46%)
·
TOI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.3803.480
52 wk Range
1.9104.880
Key Statistics
Prev. Close
3.38
Open
3.38
Day's Range
3.38-3.48
52 wk Range
1.91-4.88
Volume
1.19M
Average Vol. (3m)
1.92M
1-Year Change
76.8041%
Book Value / Share
-0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TOI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.000
Upside
+104.08%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Oncology Institute Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Oncology Institute Inc Earnings Call Summary for Q4/2025

  • Q4 2025 EPS of -$0.06 beat estimates of -$0.09; revenue rose 41.6% YoY to $141.96M, exceeding forecasts by 1.55%
  • Achieved first profitable quarter on adjusted EBITDA basis at $147K vs -$7.8M in Q4 2024; full-year revenue grew 27.8% to $502.7M
  • Pharmacy segment revenue surged 49.6%; implemented delegated capitation model in Florida with new major health plan partnerships
  • Stock rose 3.26% aftermarket to $2.85; analysts set price targets of $5-$8, indicating significant upside potential from current levels
  • Q1 2026 revenue guidance of $143.04M; plans to enhance pharmacy platform and expand network portal in Q2 2026 for improved operations
Last Updated: 03/12/2026, 06:36 PM
Read Full Transcript

Compare TOI to Peers and Sector

Metrics to compare
TOI
Peers
Sector
Relationship
P/E Ratio
−6.7x6.4x−0.5x
PEG Ratio
−0.290.130.00
Price / Book
−21.6x3.3x2.6x
Price / LTM Sales
0.7x1.2x3.2x
Upside (Analyst Target)
118.7%41.5%45.7%
Fair Value Upside
Unlock5.1%4.8%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.000
(+104.08% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy8.00+133.24%6.00MaintainMar 13, 2026
Needham
Buy5.00+45.77%-New CoverageNov 25, 2025
BTIG
Buy7.00+104.08%-MaintainAug 14, 2025
Noble Capital
Buy8.00+133.24%-New CoverageJul 23, 2025
B.Riley
Buy6.00+74.93%-New CoverageJul 16, 2025

Earnings

Latest Release
Mar 12, 2026
EPS / Forecast
-0.06 / -0.09
Revenue / Forecast
141.96M / 139.79M
EPS Revisions
Last 90 days

TOI Income Statement

People Also Watch

4.17
ANNA
-0.71%
2.890
MOBX
+9.89%
1.580
AIFF
+1.28%
3.30
BATL
-1.49%

FAQ

What Is the Oncology Institute (TOI) Stock Price Today?

The Oncology Institute stock price today is 3.430 USD.

What Stock Exchange Does Oncology Institute Trade On?

Oncology Institute is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Oncology Institute?

The stock symbol for Oncology Institute is "TOI."

What Is the Oncology Institute Market Cap?

As of today, Oncology Institute market cap is 339.020M USD.

What Is Oncology Institute's Earnings Per Share (TTM)?

The Oncology Institute EPS (TTM) is -0.545.

When Is the Next Oncology Institute Earnings Date?

Oncology Institute will release its next earnings report on May 13, 2026.

From a Technical Analysis Perspective, Is TOI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Oncology Institute Stock Split?

Oncology Institute has split 0 times.

How Many Employees Does Oncology Institute Have?

Oncology Institute has 641 employees.

What is the current trading status of Oncology Institute (TOI)?

As of Apr 16, 2026, Oncology Institute (TOI) is trading at a price of 3.430 USD, with a previous close of 3.380 USD. The stock has fluctuated within a day range of 3.380 USD to 3.480 USD, while its 52-week range spans from 1.910 USD to 4.880 USD.

What Is Oncology Institute (TOI) Price Target According to Analysts?

The average 12-month price target for Oncology Institute is 7.000 USD, with a high estimate of 8 USD and a low estimate of 5 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +104.08% Upside potential.

What Is the TOI Premarket Price?

TOI's last pre-market stock price is 3.410 USD. The pre-market share volume is 16,970.000, and the stock has decreased by 0.030, or 0.890%.

What Is the TOI After Hours Price?

TOI's last after hours stock price is 3.480 USD, the stock has decreased by 0.050, or 1.460%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.